Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

Oral morphine effective for management of sickle cell pain in children

Dec. 16, 1997

CerAxon submitted for approval in U.S.

Dec. 16, 1997

5-HT receptor (ant)agonists from Pfizer

Dec. 16, 1997

Migranal Nasal Spray approved by FDA

Dec. 15, 1997

Bupropion: drug of choice for depression in males with erectile dysfunction?

Dec. 15, 1997

OPC-14597: a novel D2 antagonist/DA autoreceptor agonist for schizophrenia

Dec. 15, 1997

Daiichi files for approval of ebselen

Dec. 12, 1997

Potent and selective dopamine D4 antagonist discovered at Yamanouchi

Dec. 11, 1997

Preclinical and preliminary clinical profile of NE-100, a new antipsychotic drug

Dec. 11, 1997

DepoMorphine enters phase II trials

Dec. 10, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 24, 2026.
4D Nucleome opens new wave of gene regulation research, discovery
BioWorld
After a decade of research, the NIH 4D Nucleome program on July 23 delivered a wealth of new insights into how spatial changes in chromatin structure and DNA...
Brain-penetrant NLRP3 inhibitor shows promise in Parkinson’s
BioWorld Science
Researchers from Changchun Genescience Pharmaceuticals Co. Ltd. described the discovery and preclinical profile of an NLRP3 inhibitor with favorable brain...
Transcripta Bio raises funding to advance neuro pipeline
BioWorld Science
Transcripta Bio Inc. has raised $24 million since its series A to fund IND-enabling studies across its portfolio and support clinical preparation in its autism...
Other news to note for July 22, 2026
BioWorld
Biopharma and med-tech happenings, including deals and partnerships, and other news in brief: Akari, Ashlins, Azurity, Eli Lilly, Engitix, Forge Biologics,...